Good MorningEquity markets continued to advance on Tuesday, although the pace of gains slowed. The S&P 500 advanced 0.20% after tepid results from blue-chip giant Walt Disney and others sapped enthusiasm for risk-on assets. Walt Disney reported good results but in alignment with expectations, giving no catalyst for a rally. The S&P may continue higher over the next few trading sessions but there is risk of slowing momentum and topping out near the all-time highs.
The next major hurdles for the market will come next week. The CPI data is due on Wednesday and is unlikely to alter the Fed outlook. Earnings reports from the retail sector are another hurdle for equities. Reports from leaders like Walmart and Home Depot are due early in the week and may provide an unwanted surprise. Reports from McDonald's, Coca-Cola, Kraft Heinz, and Starbucks reveal a pinched consumer that may show in the retail results. Investors should expect weakness generally and market-leading strength from the off-price segment. Featured: Wall Street’s quietly buying these 3 AI infrastructure plays (Ad) 
|
Technology | | Upwork Inc. (NASDAQ: UPWK) is the largest online freelancer platform in the world, with over 870,000 active clients. The computer and technology sector giant has been making a concentrated push to become a top artificial intelligence (AI) freelance work hub, partnering with OpenAI, GoDaddy Inc. (NYS... Read the Full Story |
|
From Our Partners | | BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one that gets burned with every transaction on what analysts are calling America's new financial grid.
The Nasdaq has received SEC approval to move stocks onto blockchain rails, and BlackRock CEO Larry Fink dedicated his entire 2026 annual letter to this infrastructure shift. Blockchain analyst Andy Howard is calling this asset 'Digital Oil' - and says institutional buyers are already positioned. | | Get the name, the ticker, and exactly how to buy it |
|
Technology | | Garmin Ltd. (NYSE: GRMN) launched in 1989 with the sole focus of providing GPS devices for consumers. Years later, the advent of smartphone GPS apps like Google Maps, Apple Maps, and Waze could have spelled death for the company. However, the computer and technology sector giant has thrived by branc... Read the Full Story |
|
Technology | | Social commerce platform Pinterest Inc. (NYSE: PINS) shares are climbing towards 52-week highs on the heels of a spectacular Q1 2024 earnings report. The rebound in the advertising market, coupled with its artificial intelligence (AI) powered personalization and shop-ability effects, bolstered the c... Read the Full Story |
|
From Our Partners | | See the Signals Most Traders Miss
We monitor subtle shifts in order flow, volume patterns, and early trend behavior.
Stock News Trends highlights moves long before they hit mainstream screens. | | Join Free — Start Tracking Early Market Data |
|
Medical | |
Shares of AbbVie (NYSE: ABBV) fell hard in the wake of its Q1 earnings report, but the dip is over. The market response to slowing Humira sales is overshadowed by strength in the non-Humira portfolio, resilient business, and a solid pipeline. Analysts trimmed their targets following the release, b... Read the Full Story |
|
Markets | | The latest ISM manufacturing PMI index suggests that the turning point for the automotive stock sector is imminent. According to the report, a member of the primary metals industry was quoted as saying that "automotive builds continue at averages but not near maximum outputs." This could translate t... Read the Full Story |
|
From Our Partners | | With OpenAI and Anthropic moving closer to the IPO spotlight, AI excitement could spill into several public-market sectors this summer - and most investors may chase the obvious names too late.
A free report identifies 7 stocks positioned around themes that could matter most this summer: AI infrastructure, energy demand, travel, entertainment, home improvement, and more. Built for a market where leadership may rotate quickly. | | Download 7 Best Stocks to Own in Summer 2026 for free |
|
Consumer Staples | |
Freshpet’s (NASDAQ: FRPT) Q1 results led the market to a 10% gain, and more fresh highs are coming. The primary takeaway is that volume gains underpin growth and provide significant leverage for this business. Headwinds remain; costs and quality are always an issue, but the stage is set for ... Read the Full Story |
|
Markets | |
Shares of Hims & Hers Health Inc. (NYSE: HIMS) are jumping by as much as 15.5% after the company released its first quarter 2024 earnings results. This quarter is arguably the most important quarter as it sets the tone for the rest of the year in any stock. In the case of Hims & Hers stock... Read the Full Story |
|
Utilities | |
As they say, Penny stocks are a dime-a-dozen, making picking unique penny stock investments a challenge. Among the many indicators penny stock investors can use is insider buying. Insider buying doesn’t guarantee investment success for penny stocks, but it alleviates some of the risks. Insid... Read the Full Story |
|
Technology | |
Palantir Technologies Inc. (NYSE: PLTR) delivered a solid earnings report, but you wouldn't know it if you looked at the share price. PLTR stock is down over 11% in pre-market trading. You could look at this as a reaction to weaker full-year guidance. But it's more likely that traders took some pr... Read the Full Story |
|
Consumer Discretionary | |
Walt Disney (NYSE: DIS) faces headwinds like any other business, but its brand strength and operational resilience shine through. CEO Bob Iger delivered another quarter of improvements and raised guidance for earnings, which suggests a sell-the-news/buy-the-dip event is in progress. Analysts' acti... Read the Full Story |
|
Wednesday's Early Bird Stock Of The Day Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets in the United States, the United Kingdom, rest of Europe, Middle East, and Africa, Greater China, rest of Asia-Pacific, and internationally. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was incorporated in 1976 and is headquartered in Minneapolis, Minnesota. | | View Today's Stock Pick |
|
